Research & Development



  回到家里,雲瑯首先抱過閨女,讓她張大了嘴巴仔細的觀察她的乳牙。   這種人根本就無法被收買!258nba篮球彩票   “你是說那些整日里吃糠咽菜的人比我們活的長久?”258彩票   博士們的神情奇妙,只有轅固生笑吟吟的向公孫弘表示了欽佩,祝賀之意,其余博士們的臉色不是很好看,自顧自的喝酒,似乎對公孫弘丟出來的消息不是很感興趣。   “對啊,要不然那麼多的白菜怎麼吃得了啊。”3.6亿彩票大奖作假   所以啊,像你這種傻蛋一定要听聰明人的,把今晚的討論事項給陛下一五一十的報上去,如果有些事情理解不了,就看我給你寫的提要,盡量潤色的花團錦簇一些。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo